| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0065-2571(01)00034-6 |
| P698 | PubMed publication ID | 12123721 |
| P2093 | author name string | Janko Kos | |
| Vito Turk | |||
| Boris Turk | |||
| Dusan Turk | |||
| Gregor Guncar | |||
| P2860 | cites work | Cystatin F is a glycosylated human low molecular weight cysteine proteinase inhibitor | Q24312357 |
| Cystatin E is a novel human cysteine proteinase inhibitor with structural resemblance to family 2 cystatins | Q24312902 | ||
| Oligomeric Structure and Substrate Induced Inhibition of Human Cathepsin C | Q24337142 | ||
| Lysosomal cysteine proteases: facts and opportunities | Q24535678 | ||
| Structure of human procathepsin L reveals the molecular basis of inhibition by the prosegment | Q24561952 | ||
| Friends and relations of the cystatin superfamily--new members and their evolution | Q24673719 | ||
| Major histocompatibility complex class II-associated p41 invariant chain fragment is a strong inhibitor of lysosomal cathepsin L | Q24678337 | ||
| Crystal structure of MHC class II-associated p41 Ii fragment bound to cathepsin L reveals the structural basis for differentiation between cathepsins L and S. | Q27617244 | ||
| Inhibition mechanism of cathepsin L-specific inhibitors based on the crystal structure of papain-CLIK148 complex | Q27620728 | ||
| Crystal structure of cathepsin X: a flip-flop of the ring of His23 allows carboxy-monopeptidase and carboxy-dipeptidase activity of the protease | Q27622021 | ||
| Structure of human dipeptidyl peptidase I (cathepsin C): exclusion domain added to an endopeptidase framework creates the machine for activation of granular serine proteases | Q27636471 | ||
| The refined 2.15 A X-ray crystal structure of human liver cathepsin B: the structural basis for its specificity | Q27651464 | ||
| Crystal structure of cathepsin B inhibited with CA030 at 2.0-A resolution: A basis for the design of specific epoxysuccinyl inhibitors | Q27730182 | ||
| Crystal structure of human cathepsin K complexed with a potent inhibitor | Q27734780 | ||
| Crystal structure of human osteoclast cathepsin K complex with E-64 | Q27734783 | ||
| Crystal structure of porcine cathepsin H determined at 2.1 A resolution: location of the mini-chain C-terminal carboxyl group defines cathepsin H aminopeptidase function | Q27748903 | ||
| On the size of the active site in proteases. I. Papain | Q27860826 | ||
| The residual pro-part of cathepsin C fulfills the criteria required for an intramolecular chaperone in folding and stabilizing the human proenzyme | Q28140187 | ||
| The cystatins: Protein inhibitors of cysteine proteinases | Q28283958 | ||
| The p41 isoform of invariant chain is a chaperone for cathepsin L | Q28345078 | ||
| Cathepsin S required for normal MHC class II peptide loading and germinal center development | Q28611850 | ||
| Cathepsin L: critical role in Ii degradation and CD4 T cell selection in the thymus | Q28613227 | ||
| Cathepsin B acts as a dominant execution protease in tumor cell apoptosis induced by tumor necrosis factor | Q30481000 | ||
| Probing the specificity of cysteine proteinases at subsites remote from the active site: analysis of P4, P3, P2' and P3' variations in extended substrates. | Q30848784 | ||
| Expression of cathepsins B and S in the progression of prostate carcinoma | Q32160033 | ||
| Intracellular transport and peptide loading of MHC class II molecules: regulation by chaperones and motors | Q33815425 | ||
| Unraveling the role of proteases in cancer | Q33838143 | ||
| Cathepsin D in breast cancer: mechanisms and clinical applications, a 1999 overview | Q33838156 | ||
| Lysosomal cysteine proteases: more than scavengers | Q33857460 | ||
| Human cathepsin X: A cysteine protease with unique carboxypeptidase activity | Q33875510 | ||
| Cysteine proteinases and their inhibitors in extracellular fluids: markers for diagnosis and prognosis in cancer. | Q33890759 | ||
| The p41 fragment story | Q33904228 | ||
| Antigen-processing machinery breakdown and tumor growth | Q34011098 | ||
| Cathepsin S controls the trafficking and maturation of MHC class II molecules in dendritic cells. | Q36301521 | ||
| Cathepsins B and D are dispensable for major histocompatibility complex class II-mediated antigen presentation | Q36475793 | ||
| Cathepsin S activity regulates antigen presentation and immunity | Q37382422 | ||
| Cathepsin S in tumours, regional lymph nodes and sera of patients with lung cancer: relation to prognosis | Q38281556 | ||
| Intracellular proteases | Q39664942 | ||
| Invasion of ras-transformed breast epithelial cells depends on the proteolytic activity of cysteine and aspartic proteinases | Q40784508 | ||
| Lysosomal protease pathways to apoptosis. Cleavage of bid, not pro-caspases, is the most likely route | Q40843079 | ||
| Lack of class II transactivator causes severe deficiency of HLA-DR expression in small cell lung cancer | Q40948614 | ||
| MHC class II restricted antigen presentation | Q41353041 | ||
| Endosomal proteolysis and MHC class II function | Q41729834 | ||
| Revised definition of substrate binding sites of papain-like cysteine proteases | Q41730414 | ||
| Characterization by spectroscopic, kinetic and equilibrium methods of the interaction between recombinant human cystatin A (stefin A) and cysteine proteinases | Q42160442 | ||
| Crystal structure of human cathepsin S. | Q42846520 | ||
| Cathepsin S regulates the expression of cathepsin L and the turnover of gamma-interferon-inducible lysosomal thiol reductase in B lymphocytes | Q43578153 | ||
| Human recombinant pro-dipeptidyl peptidase I (cathepsin C) can be activated by cathepsins L and S but not by autocatalytic processing | Q43591595 | ||
| Immunochemical localisation of cathepsin S, cathepsin L and MHC class II-associated p41 isoform of invariant chain in human lymph node tissue | Q43716326 | ||
| Cathepsin B/cystatin C complex levels in sera from patients with lung and colorectal cancer. | Q43716328 | ||
| Cancer. Proteases--invasion and more | Q47676048 | ||
| Developmental regulation of invariant chain proteolysis controls MHC class II trafficking in mouse dendritic cells. | Q47872621 | ||
| Acidic pH as a physiological regulator of human cathepsin L activity. | Q52534368 | ||
| Thyroglobulin type-1 domains in equistatin inhibit both papain-like cysteine proteinases and cathepsin D. | Q53744558 | ||
| Potent slow-binding inhibition of cathepsin B by its propeptide | Q67974285 | ||
| Participation of cathepsin L on bone resorption | Q70670024 | ||
| Lymphoid monoclonal antibodies reactive with lung tumors. Diagnostic applications | Q70835069 | ||
| Lysosomal proteases cathepsins D, B, H, L and their inhibitors stefins A and B in head and neck cancer | Q71782469 | ||
| Kinetics of the pH-induced inactivation of human cathepsin L | Q72067273 | ||
| Peptidyl diazomethanes as inhibitors of cysteine and serine proteinases | Q72519434 | ||
| Cystatins | Q72519445 | ||
| Purification of the complex of cathepsin L and the MHC class II-associated invariant chain fragment from human kidney | Q72709864 | ||
| Human cathepsin B is a metastable enzyme stabilized by specific ionic interactions associated with the active site | Q72891339 | ||
| Potency and selectivity of inhibition of cathepsin K, L and S by their respective propeptides | Q73023870 | ||
| A fragment of the major histocompatibility complex class II-associated p41 invariant chain inhibits cruzipain, the major cysteine proteinase from Trypanosoma cruzi | Q73025834 | ||
| Structure based development of novel specific inhibitors for cathepsin L and cathepsin S in vitro and in vivo | Q73077056 | ||
| Inhibition of carcinoma cell invasion and liver metastases formation by the cysteine proteinase inhibitor E-64 | Q73135950 | ||
| Fluorometric microassays for the determination of cathepsin L and cathepsin S activities in tissue extracts | Q73137144 | ||
| Anti-human procathepsin D activation peptide antibodies inhibit breast cancer development | Q73316231 | ||
| Saxiphilin, a saxitoxin-binding protein with two thyroglobulin type 1 domains, is an inhibitor of papain-like cysteine proteinases | Q73626504 | ||
| Biochemical characterization of human cathepsin X revealed that the enzyme is an exopeptidase, acting as carboxymonopeptidase or carboxydipeptidase | Q74198942 | ||
| Impaired invariant chain degradation and antigen presentation and diminished collagen-induced arthritis in cathepsin S null mice | Q74595052 | ||
| Interaction of cystatin C variants with papain and human cathepsins B, H and L | Q78119067 | ||
| P304 | page(s) | 285-303 | |
| P577 | publication date | 2002-01-01 | |
| P1433 | published in | Advances in Enzyme Regulation | Q15756443 |
| P1476 | title | Lysosomal cathepsins: structure, role in antigen processing and presentation, and cancer | |
| P478 | volume | 42 |
| Q36072142 | Atorvastatin inhibits the apoptosis of human umbilical vein endothelial cells induced by angiotensin II via the lysosomal-mitochondrial axis |
| Q34163170 | Autophagy activation aggravates neuronal injury in the hippocampus of vascular dementia rats |
| Q47910895 | CA/C1 peptidases of the malaria parasites Plasmodium falciparum and P. berghei and their mammalian hosts--a bioinformatical analysis |
| Q40426125 | Carboxypeptidases cathepsins X and B display distinct protein profile in human cells and tissues |
| Q39640572 | Cathepsin S Activity Controls Injury-Related Vascular Repair in Mice via the TLR2-Mediated p38MAPK and PI3K-Akt/p-HDAC6 Signaling Pathway. |
| Q34320916 | Cathepsin cysteine proteases are effectors of invasive growth and angiogenesis during multistage tumorigenesis |
| Q54627475 | Cathepsin-L contributes to cardiac repair and remodelling post-infarction. |
| Q37161711 | Cathepsins B and D drive hepatic stellate cell proliferation and promote their fibrogenic potential |
| Q39237735 | Cathepsins in digestive cancers |
| Q48085339 | Cloning and characterization of protease inhibitor-like cDNAs from the Hessian fly mayetiola destructor (SAY). |
| Q55042196 | Cystatin C, kidney function and cardiovascular disease. |
| Q26860406 | Cysteine cathepsins: from structure, function and regulation to new frontiers |
| Q27311493 | Deficiency for the cysteine protease cathepsin L impairs Myc-induced tumorigenesis in a mouse model of pancreatic neuroendocrine cancer |
| Q38784171 | Degradomics in Neurotrauma: Profiling Traumatic Brain Injury |
| Q34471105 | Distinct roles for cysteine cathepsin genes in multistage tumorigenesis |
| Q64991702 | Ectromelia virus suppresses expression of cathepsins and cystatins in conventional dendritic cells to efficiently execute the replication process. |
| Q38647522 | Effects of Vacuolar H(+)-ATPase Inhibition on Activation of Cathepsin B and Cathepsin L Secreted from MDA-MB231 Breast Cancer Cells. |
| Q36682721 | Effects of open versus laparoscopic nephrectomy techniques on oxidative stress markers in patients with renal cell carcinoma |
| Q41913958 | Endolysosomal processing of exogenous antigen into major histocompatibility complex class I-binding peptides |
| Q40284265 | Evidence for inactivation of cysteine proteases by reactive carbonyls via glycation of active site thiols |
| Q34804966 | Expression Analysis of Cathepsin F during Embryogenesis and Early Developmental Stage in Olive Flounder (Paralichthys olivaceus) |
| Q43151758 | Expression and activity profiling of selected cysteine cathepsins and matrix metalloproteinases in synovial fluids from patients with rheumatoid arthritis and osteoarthritis |
| Q40356048 | Expression of cathepsin L in human tumor cells is under the control of distinct regulatory mechanisms |
| Q45391769 | Expressional induction of Paralichthys olivaceus cathepsin B gene in response to virus, poly I:C and lipopolysaccharide |
| Q33815880 | Extracellular cystatin SN and cathepsin B prevent cellular senescence by inhibiting abnormal glycogen accumulation |
| Q91709813 | Fluorescent probes towards selective cathepsin B detection and visualization in cancer cells and patient samples |
| Q44164012 | Folding, stability, and secondary structure of a new dimeric cysteine proteinase inhibitor |
| Q40634193 | Functional proteomics of the active cysteine protease content in Drosophila S2 cells |
| Q37469304 | Gamma-IFN-inducible-lysosomal thiol reductase modulates acidic proteases and HLA class II antigen processing in melanoma |
| Q36441936 | Giardia lamblia cysteine proteases |
| Q33280427 | Heterogeneity of proteinase inhibitors in the water-soluble organic matrix from the oyster nacre |
| Q47413838 | High molecular weight kininogen as substrate for cathepsin B. |
| Q35561019 | Hydrogen ion dynamics and the Na+/H+ exchanger in cancer angiogenesis and antiangiogenesis. |
| Q36801110 | IGFBP-4 anti-angiogenic and anti-tumorigenic effects are associated with anti-cathepsin B activity |
| Q40123189 | Increased carcinogenic potential of myeloid tumor cells induced by aberrant TGF-beta1-signaling and upregulation of cathepsin B. |
| Q83575417 | Increased invasiveness of MMP-9-deficient tumors in two mouse models of neuroendocrine tumorigenesis |
| Q94505689 | Inhibition of mammalian cathepsins by Plesiomonas shigelloides |
| Q46686104 | Inhibitory fragment from the p41 form of invariant chain can regulate activity of cysteine cathepsins in antigen presentation. |
| Q27024355 | Macrophage derived cystatin B/cathepsin B in HIV replication and neuropathogenesis |
| Q38237985 | Metastasis review: from bench to bedside |
| Q45146040 | Microarray analysis of differentially expressed genes in rat frontal cortex under chronic risperidone treatment |
| Q37570507 | Mitochondrial turnover and aging of long-lived postmitotic cells: the mitochondrial-lysosomal axis theory of aging |
| Q47099045 | Modeling of autophagy-related gene expression dynamics during long term fasting in European eel (Anguilla anguilla). |
| Q30888032 | Phylogenomic analysis of the cystatin superfamily in eukaryotes and prokaryotes |
| Q40494861 | Poly(lactide-co-glycolide) nanoparticles as a carrier system for delivering cysteine protease inhibitor cystatin into tumor cells |
| Q64389267 | Regulating BRCA1 protein stability by cathepsin S-mediated ubiquitin degradation |
| Q38746834 | Regulation of V-ATPase assembly and function of V-ATPases in tumor cell invasiveness |
| Q42661508 | Sequence identification, tissue distribution and polymorphism of the porcine cathepsin D (CTSD) gene. |
| Q35777627 | Significance and prognostic value of lysosomal enzyme activities measured in surgically operated adenocarcinomas of the gastroesophageal junction and squamous cell carcinomas of the lower third of esophagus |
| Q27664635 | Stefin A displaces the occluding loop of cathepsin B only by as much as required to bind to the active site cleft |
| Q57665967 | Targeted analysis of lysosomal directed proteins and their sites of mannose-6-phosphate modification |
| Q37169505 | The Function of V-ATPases in Cancer |
| Q27334407 | The atypical calpains: evolutionary analyses and roles in Caenorhabditis elegans cellular degeneration |
| Q39373589 | The feasibility of enzyme targeted activation for amino acid/dipeptide monoester prodrugs of floxuridine; cathepsin D as a potential targeted enzyme |
| Q47815769 | The role of cathepsins in involution and breast cancer. |
| Q21195231 | The use of cystatin C to inhibit epithelial-mesenchymal transition and morphological transformation stimulated by transforming growth factor-beta |
| Q85341798 | Triterpenoids as novel natural inhibitors of human cathepsin L |
| Q50295291 | iTRAQ-Based Comparative Proteomic Analysis of Adult Schistosoma japonicum from Water Buffalo and Yellow Cattle |
| Q55669243 | miR-106b-5p inhibits the invasion and metastasis of colorectal cancer by targeting CTSA. |
Search more.